Óscar María Beloqui Ruiz-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

    Clinica Chimica Acta, Vol. 557

2013

  1. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

2010

  1. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

    Journal of Hypertension, Vol. 28, Núm. 11, pp. 2219-2226

  2. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension (Clinical Science (2009) 116, (233-240))

    Clinical Science

2009

  1. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension

    Clinical Science, Vol. 116, Núm. 3, pp. 233-240

2006

  1. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis

    Journal of the American College of Cardiology, Vol. 47, Núm. 7, pp. 1369-1378

2005

  1. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

2002

  1. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives

    Hypertension, Vol. 39, Núm. 4, pp. 923-928